Itolizumab, the monoclonal antibody designed in Cuba, is making its way into the world
The drug has proven effective in patients with psoriasis, COVID-19 and lupus nephritis, inside and outside Cuba.
Tag: Itolizumab
Most Read
-
Juan Triana: “The instability in the exchange rate stops business and affects everyone”
-
The “discrete results” of the government’s anti-crisis package and the “daily rate” of the new exchange rate regime
-
What foods can be brought to Cuba and what imports are forbidden?
-
Cuban population is decreasing and aging, government confirms
-
Economy 2025: Where Cuba sees growth, ECLAC sees a decline
